臨床穿戴裝置市場機會、成長要素、產業趨勢分析及2026-2035年預測

全球臨床穿戴裝置市場預計到 2025 年將達到 1,377 億美元，年複合成長率為 16.3%，到 2035 年將達到 6,179 億美元。

臨床級穿戴裝置是指經過臨床檢驗的基於感測器的醫療設備，支援生理評估、診斷、疾病管理、治療監測和遠距醫療服務。其市場定位不僅限於健康追蹤；製造商必須證明其臨床性能，獲得特定醫療應用的監管批准，保護傳輸的健康數據，並使其能夠與現有的醫療流程整合。產品線包括連續血糖監測儀、攜帶式心電圖貼片、無袖帶血壓測量技術、多參數生物感測器貼片、呼吸和睡眠監測系統以及神經系統穿戴式裝置。持續患者資料收集的需求日益成長，促使醫療服務提供者和科技公司將穿戴式監測技術融入日益分散的醫療模式中。同時，製造商必須應對證據要求、資料安全、互通性和工作流程整合等挑戰，才能實現永續的商業性化應用。隨著遠距監測和數位化醫療服務日益融入醫療服務體系，臨床級穿戴技術作為收集可操作生理資訊的工具，其重要性日益凸顯。這些趨勢表明，預計到2035年，該市場將快速成長。

預計到2025年，活動和健身監測器市場佔有率將達到25%。其龐大的使用者群體為識別可能需要進一步臨床評估的健康相關模式提供了一個成熟的平台。然而，提供臨床級產品的公司必須證明其產品在特定醫療應用中的表現，而不能僅依賴廣泛的健康功能。因此，市場參與企業越來越重視針對特定適應症的檢驗、臨床證據以及將監測結果與專業醫療保健服務聯繫起來的適當途徑。穿戴式資料在預防醫學和持續病患監測中日益重要的角色也印證了這個細分市場的重要性。隨著穿戴式科技與醫療保健流程的整合日益加深，對於旨在拓展臨床級穿戴裝置市場的製造商而言，區分消費者追蹤和臨床檢驗的監測變得愈發重要。

預計到2025年，居家照護環境領域將佔據60.2%的市場。穿戴式監測設備即使在患者不在傳統醫療機構的情況下，也能收集具有臨床意義的生理資訊。遠端監測技術的日益普及為這一模式提供了支持，而保險報銷制度的改進也為更廣泛的應用創造了更多機會。然而，僅僅收集測量數據不足以有效利用穿戴式裝置產生的資訊。醫療機構和醫護人員必須建立適當的病患教育、資料審查、分流流程和升級機制，以便將相關的測量數據與及時的照護決策連結起來。因此，遠端資料收集與結構化臨床流程的結合對於臨床級穿戴式技術的商業性成功至關重要。隨著醫療保健系統不斷將服務範圍擴展到傳統醫療機構之外，家庭監測預計將繼續為市場發展做出重大貢獻。

預計到2025年，北美臨床級穿戴裝置市佔率將達到40.4%，並在2035年之前以16.2%的複合年成長率持續成長。推動這一市場成長的因素包括：聯邦醫療保險（Medicare）的報銷、美國食品藥物管理局（FDA）的市場准入批准、完善的醫院資訊技術基礎設施以及成熟的商業分銷系統。這些因素為製造商提供了在臨床證據、監管要求以及與醫療工作流程整合方面的投資機會。此外，市售連續血糖監測設備的日益普及，正在擴大潛在用戶群體，使其不再局限於以往接受傳統胰島素治療相關監測的患者，從而促進區域市場成長。遠距醫療基礎設施的持續發展和數位醫療的普及預計將在2035年之前繼續支持北美在全球臨床級穿戴裝置市場的貢獻。

全球臨床級穿戴裝置市場的企業正透過合規監管、臨床檢驗、產品創新、策略合作、軟體整合以及拓展遠距醫療業務來提升市場佔有率。製造商正投資於改進感測器、演算法、數據平台、互通性以及支援持續生理監測的設備設計。他們也正在努力建立更強大的臨床證據體系，以支持監管申報和明確的醫療適應症。與醫療服務提供者和技術公司建立合作關係，有望加速工作流程整合並拓展部署機會。企業正在開發支援資料管理、遠端監測和病人參與的互聯平台，並專注於安全的資訊管理。拓展居家照護以及擴大消費者群體也有助於企業接觸更多患者。這些策略使市場參與企業能夠提升臨床信譽度、拓展產品系列、加速醫療保健整合、擴展分銷網路、強化持續服務機會，並在快速發展的臨床級穿戴裝置產業中確立更穩固的地位。全球臨床級穿戴裝置市場集中度適中，有五家公司——雅培、德康、Medtronic、飛利浦和瑪西莫——合計佔了全球約60%的銷售額。市場競爭受多種因素影響，包括合規能力、臨床證據、演算法開發、互通性以及在不同醫療環境中部署穿戴式裝置的能力。此外，在針對特定疾病、感測器工程或監測服務能力的證據至關重要的領域，擁有專業知識的公司能夠保持關鍵的市場地位。因此，市場參與企業不僅在設備設計方面競爭，還在配套軟體、臨床檢驗、資料管理能力以及與醫療服務系統的整合方面競爭。隨著製造商將穿戴式科技擴展到居家照護、醫院環境和虛擬醫療模式，同時滿足日益具體的臨床和監管要求，市場競爭格局也不斷演變。

目錄

第1章：調查方法

第2章執行摘要

第3章 行業洞察

• 產業生態系分析
• 影響產業的因素
  • 促進因素
    • 開發中國家的人們對健康維護和穿戴式裝置的認知正在提高。
    • 全球慢性病盛行率不斷上升
    • 穿戴式裝置的技術進步
    • 新興經濟體可支配收入和醫療保健支出不斷成長
  • 產業潛在風險與挑戰
    • 資料安全挑戰
    • 穿戴式裝置往往價格昂貴。
  • 機會
    • 遠端患者監護（RPM）計劃的擴展
    • 人工智慧 (AI) 與數位健康平台的整合
• 成長潛力分析
• 監理情勢
• 價格趨勢分析
• 技術與創新展望
  • 最新科技趨勢
  • 新興技術
• 未來市場趨勢
• 人工智慧和生成式人工智慧對市場的影響
• 波特的分析
• PESTLE分析

第4章 競爭情勢

• 介紹
• 企業矩陣分析
• 企業市佔率分析
  • 世界
  • 北美洲
  • 歐洲
  • 亞太地區
• 主要市場公司的競爭分析
• 競爭定位矩陣
• 主要進展
  • 併購
  • 夥伴關係和聯盟
  • 新產品發布
  • 業務拓展計劃

第5章 市場估價與預測：依設備分類，2022-2035年

• 活動/健身監測器
• 糖尿病醫療設備
• 心臟監測儀
• 神經監測
• 呼吸監測儀
• 體溫監測器
• 入耳式設備
• 其他設備

第6章 市場估計與預測：依應用領域分類，2022-2035年

• 心臟健康
• 預防肥胖
• 糖尿病護理
• 健身監測
• 睡眠追蹤
• 其他用途

第7章 市場估計與預測：依最終用途分類，2022-2035年

• 醫院
• 居家醫療
• 其他最終用戶

第8章 市場估計與預測：依地區分類，2022-2035年

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • UAE

第9章：公司簡介

• Abbott Laboratories
• BioIntelliSense
• Biobeat
• Boston Scientific
• Dexcom
• Empatica
• iRhythm Technologies
• LifeSignals
• Masimo
• Medtronic
• Omron Healthcare
• Philips
• Sotera Wireless
• VitalConnect
• Withings

The Global Clinical-Grade Wearables Market was valued at USD 137.7 billion in 2025 and is estimated to grow at a CAGR of 16.3% to reach USD 617.9 billion by 2035.

Clinical-grade wearables comprise sensor-based medical devices that undergo clinical validation and support physiological assessment, diagnosis, disease management, treatment monitoring, and remote healthcare delivery. Their market position depends on more than basic health tracking, as manufacturers must demonstrate clinical performance, obtain regulatory authorization for specific medical uses, protect transmitted health data, and enable integration with established care processes. The product landscape covers continuous glucose monitors, ambulatory ECG patches, cuffless blood-pressure technologies, multiparameter biosensor patches, respiratory and sleep-monitoring systems, and neurological wearable devices. Growing demand for continuous patient data is encouraging healthcare providers and technology companies to incorporate wearable monitoring into increasingly distributed care models. At the same time, manufacturers must address evidence requirements, data security, interoperability, and workflow adoption to achieve sustained commercial uptake. As healthcare delivery increasingly incorporates remote monitoring and digitally enabled care, clinical-grade wearable technologies are gaining importance as tools for collecting actionable physiological information. These developments are expected to support rapid market expansion through 2035.

Activity and fitness monitors segment accounted for 25% share in 2025. Their extensive user base provides an established platform for identifying health-related patterns that may warrant further clinical assessment. However, clinical-grade providers must demonstrate performance for defined medical applications rather than relying solely on broad wellness functionality. Market participants are therefore placing greater emphasis on indication-specific validation, clinical evidence, and appropriate pathways that connect monitoring results with professional healthcare services. The segment's continued relevance is supported by the expanding role of wearable data in preventive health and ongoing patient monitoring. As wearable technologies become increasingly connected to healthcare processes, the distinction between consumer-oriented tracking and clinically validated monitoring is becoming more important for manufacturers seeking to expand within the clinical-grade wearables market.

Home care settings segment accounted for 60.2% share in 2025. Wearable monitoring enables clinically relevant physiological information to be gathered while patients remain outside traditional healthcare facilities. The growing availability of remote monitoring technologies is supporting this model, while improvements in reimbursement are creating additional opportunities for broader deployment. However, successful use of wearable-generated information requires more than collecting measurements. Healthcare organizations and providers must establish appropriate patient education, data review, triage procedures, and escalation pathways so that relevant readings can be translated into timely care decisions. The combination of remote data collection and structured clinical processes is therefore becoming increasingly important to the commercial success of clinical-grade wearable technologies. As healthcare systems continue expanding care beyond conventional facilities, home-based monitoring is expected to remain a major contributor to market development.

North America Clinical-Grade Wearables Market recorded 40.4% share in 2025 and is projected to expand at a 16.2% CAGR through 2035. Several market characteristics support this expansion, including Medicare reimbursement, FDA market access, established hospital information-technology infrastructure, and developed commercial distribution capabilities. These conditions provide manufacturers with opportunities to invest in clinical evidence, regulatory requirements, and integration with healthcare workflows. The regional market is also expanding as over-the-counter continuous glucose monitoring becomes more accessible, broadening the potential user population beyond individuals traditionally receiving monitoring associated with insulin treatment. Continued development of remote care infrastructure and digital health adoption is expected to support North America's contribution to the global clinical-grade wearables market through 2035.

Companies in the global clinical grade wearables market are strengthening their presence through regulatory development, clinical validation, product innovation, strategic partnerships, software integration, and expansion into remote-care applications. Manufacturers are investing in improved sensors, algorithms, data platforms, interoperability, and device designs that support continuous physiological monitoring. Companies are also building stronger clinical evidence programs to support regulatory submissions and defined medical indications. Partnerships with healthcare providers and technology organizations can improve workflow integration and expand deployment opportunities. Businesses are developing connected platforms that support data management, remote monitoring, and patient engagement while emphasizing secure information handling. Expansion into home-based care and broader consumer access is also helping companies reach additional patient populations. These strategies enable market participants to strengthen clinical credibility, broaden product portfolios, improve healthcare integration, expand distribution, enhance recurring service opportunities, and establish stronger positions within the rapidly developing clinical-grade wearables industry. The global clinical-grade wearables market is moderately concentrated, with Abbott, Dexcom, Medtronic, Philips, and Masimo together accounting for approximately 60% of global revenue. Competition is shaped by several factors, including regulatory capabilities, clinical evidence, algorithm development, interoperability, and the ability to support wearable deployment across different healthcare environments. Companies with specialized expertise can also maintain important market positions where disease-focused evidence, sensor engineering, or monitoring-service capabilities carry significant weight. Market participants are therefore competing not only through device design but also through supporting software, clinical validation, data-management capabilities, and integration with healthcare delivery systems. The competitive landscape continues to evolve as manufacturers seek to expand wearable technologies across home-based care, hospital environments, and virtual healthcare models while meeting increasingly specific clinical and regulatory requirements.

Table of Contents

Chapter 1 Research Methodology

• 1.1 Research approach
• 1.2 Quality commitments
  • 1.2.1 GMI AI policy & data integrity commitment
    • 1.2.1.1 Source consistency protocol
• 1.3 Research trail & confidence scoring
  • 1.3.1 Research trail components
  • 1.3.2 Scoring components
• 1.4 Data collection
  • 1.4.1 Partial list of primary sources
• 1.5 Data mining sources
  • 1.5.1 Paid sources
    • 1.5.1.1 Sources, by region
• 1.6 Base estimates and calculations
  • 1.6.1 Base year calculation
• 1.7 Forecast model
  • 1.7.1 Quantified market impact analysis
    • 1.7.1.1 Mathematical impact of growth parameters on forecast
• 1.8 Research transparency addendum
  • 1.8.1 Source attribution framework
  • 1.8.2 Quality assurance metrics
  • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Device trends
  • 2.2.3 Application trends
  • 2.2.4 End use trends
• 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing awareness about physical fitness and wearable devices among the population in developing countries.
    • 3.2.1.2 Growing prevalence of chronic diseases globally
    • 3.2.1.3 Technological advancements in wearable devices.
    • 3.2.1.4 Rising disposable income and healthcare expenditure in emerging countries.
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Issues related to data security.
    • 3.2.2.2 Cost-intensive nature of wearable devices.
  • 3.2.3 Opportunities
    • 3.2.3.1 Expansion of remote patient monitoring (RPM) Programs
    • 3.2.3.2 Integration of artificial intelligence (AI) and Digital Health Platforms
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East and Africa
• 3.5 Pricing trend analysis
• 3.6 Technology and innovation landscape (Driven by Primary Research)
  • 3.6.1 Current technological trends
  • 3.6.2 Emerging technologies
• 3.7 Future market trends (Driven by Primary Research)
• 3.8 Impact of AI & Generative AI on the Market (Driven by Primary Research)
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis (Driven by Primary Research)
  • 4.3.1 Global
  • 4.3.2 North America
  • 4.3.3 Europe
  • 4.3.4 Asia Pacific
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Device, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Activity/fitness monitors
• 5.3 Diabetes devices
• 5.4 Cardiac monitors
• 5.5 Neurological monitors
• 5.6 Respiratory monitors
• 5.7 Body & temperature monitors
• 5.8 In-ear devices
• 5.9 Other devices

Chapter 6 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Cardiac health
• 6.3 Obesity control
• 6.4 Diabetes care
• 6.5 Fitness monitoring
• 6.6 Sleep tracking
• 6.7 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Home care settings
• 7.4 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 MEA
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Abbott Laboratories
• 9.2 BioIntelliSense
• 9.3 Biobeat
• 9.4 Boston Scientific
• 9.5 Dexcom
• 9.6 Empatica
• 9.7 iRhythm Technologies
• 9.8 LifeSignals
• 9.9 Masimo
• 9.10 Medtronic
• 9.11 Omron Healthcare
• 9.12 Philips
• 9.13 Sotera Wireless
• 9.14 VitalConnect
• 9.15 Withings